UNSPSC 51101655: Emetine

This classification denotes an antiprotozoal agent with the molecular formula C29H40N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X8D5EPO80M, chemically known as 2h-benzo(a)quinolizine, 3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-((1,2,3,4-tetrahydro-6,7-dimethoxy-1-isoquinolyl)methyl)- but generally known as emetine, which bears US NIH Compound Identifier 9426. European Medicines Agency schedules Emetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01877MIG.

UNSPSC 51101655 Emetine, a Commodity code, does not map to the work state and local governments are actually buying in recent solicitations tagged under it. The code nominally denotes a specific pharmaceutical alkaloid, but recent opportunities show state and local procurement activity centered on naloxone, prescription pharmaceuticals, over-the-counter products, and medical and first aid supplies — none of which are emetine or direct substitutes for it. The mismatch between the code's narrow chemical name and the broad pharmaceutical and medical-supply procurement activity tagged against it suggests either a tagging error in the underlying source data or a systemic drift in how this code is applied in state and local procurement systems. The issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The geographic spread across Florida, Texas, Florida again, and Minnesota indicates activity in multiple regions, though the sample is small and may not reflect sustained or concentrated demand for the commodity as nominally defined.

Representative recent opportunities include Seminole County's competitive bid (IFB60459723LAS) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries due by July 26, 2026 (note: the source contains a date discrepancy, listing both July 2023 and 2026; the posted date of June 30, 2026 suggests the response deadline is in 2026); the Texas Health and Human Services Commission's Request for Information (HHS0017013) on direct-to-manufacturer prescription programs, with responses due April 3, 2026; the City of Tampa's ITB for medical and first aid supplies (26P00145) for the Fire Department Rescue Division, covering 169 line items with a sealed-bid deadline of March 13, 2026 and an estimated contract value of $700,000, designated as a sheltered procurement for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products across state and local government facilities, with proposals due March 26, 2026 and contract effectiveness set for July 1, 2026.